Method of reducing the harmful effects of orally or transdermally delivered nicotine

Details for Australian Patent Application No. 2004251635 (hide)

Owner Vector Tobacco Ltd.

Inventors Conkling, Mark

Agent Davies Collison Cave

Pub. Number AU-A-2004251635

PCT Pub. Number WO2005/000352

Priority 60/475,945 04.06.03 US

Filing date 27 May 2004

Wipo publication date 6 January 2005

International Classifications

A61K 41/00 (2006.01) Medicinal preparations obtained by treating materials with wave energy or particle radiation

A01H 5/00 (2006.01) Products

A01N 43/04 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

Event Publications

15 December 2005 PCT application entered the National Phase

  PCT publication WO2005/000352 Priority application(s): WO2005/000352

24 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004251636-Combination of an NMDA receptor antagonist and a selective serotonin reuptake inhibitor for the treatment of depression and other mood disorders

2004251625-Synthesis of high molecular weight ironsaccharidic complexes